Author:
Pakbaz Sara,Hodgson Anjelica,Mete Ozgur
Publisher
Springer International Publishing
Reference12 articles.
1. Eng, C. (2001, November 29). PTEN hamartoma tumor syndrome. [Updated 2016 Jun 2]. In: M. P. Adam , H. H. Ardinger, R. A. Pagon, et al., (Eds.). GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2019. https://www.ncbi.nlm.nih.gov/books/NBK1488/
2. Hobert, J., & Eng, C. (2009). PTEN hamartoma tumor syndrome: An overview. Genetics in Medicine, 11, 687–694.
3. Lindhurst, M. J., Sapp, J. C., Teer, J. K., Johnston, J. J., Finn, E. M., Peters, K., et al. (2011). A mosaic activating mutation in AKT1 associated with the Proteus syndrome. The New England Journal of Medicine, 365(7), 611–619.
4. Marsh, D. J., Coulon, V., Lunetta, K. L., Rocca-Serra, P., Dahia, P. L., Zheng, Z., et al. (1998). Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molecular Genetics, 7, 507–515.
5. Mester, J. L., Tilot, A. K., Rybicki, L. A., Frazier, T. W., 2nd, & Eng, C. (2011). Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in PTEN knock-in murine model. European Journal of Human Genetics: EJHG, 19(7), 763–768.